Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Dendritic Cell Sarcoma, Interdigitating × obinutuzumab × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 28 Lymphoma, Follicular 16 Lymphoma, Non-Hodgkin 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Mantle-Cell 6 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia 3 Neoplasms 2 Bronchiolitis Obliterans Syndrome 2 Tumor Lysis Syndrome 1 Solid Tumors 1 Recurrence 1 Oncology Patients Receiving Chemotherapy 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Leukemia, Prolymphocytic, B-Cell 1 Leukemia, Lymphoid 1 Leukemia, Hairy Cell 1 Indolent Non-Hodgkin's Lymphoma 1 Chromosome 17 deletion 1 Carcinoma, Non-Small-Cell Lung 1 B-cell Malignancies 1 Anemia 1

Interventions

fludarabine phosphate 23 Cyclophosphamide 22 Whole-Body Irradiation 20 Mycophenolic Acid 17 Peripheral Blood Stem Cell Transplantation 15 Busulfan 14 Cyclosporine 12 Tacrolimus 10 Melphalan 10 Antilymphocyte Serum 9 Cord Blood Stem Cell Transplantation 7 Rituximab 6 Radiotherapy 6 Methotrexate 6 Filgrastim 6 Etoposide 6 fludarabine 5 Methylprednisolone 5 Granulocyte Colony-Stimulating Factor 4 Vincristine 3 Thiotepa 3 Sirolimus 3 Prednisone 3 Methylprednisolone Hemisuccinate 3 Methylprednisolone Acetate 3 Doxorubicin 3 Cytarabine 3 Carboplatin 3 Alemtuzumab 3 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡